MEDIFAST Financial Statements From 2010 to 2024

MED Stock  USD 32.44  0.03  0.09%   
MEDIFAST INC financial statements provide useful quarterly and yearly information to potential MEDIFAST INC investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on MEDIFAST INC financial statements helps investors assess MEDIFAST INC's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting MEDIFAST INC's valuation are summarized below:
Gross Profit
1.1 B
Profit Margin
0.0927
Market Capitalization
353.5 M
Enterprise Value Revenue
0.2008
Revenue
1.1 B
There are over one hundred nineteen available fundamental ratios for MEDIFAST INC, which can be analyzed over time and compared to other ratios. Investors should ensure to check all of MEDIFAST INC's last-minute performance against the performance from 2010 to 2024 to make sure the company is sustainable in the future. The current year's Market Cap is expected to grow to about 465.9 M. The current year's Enterprise Value is expected to grow to about 417.1 M

MEDIFAST INC Total Revenue

1.13 Billion

Check MEDIFAST INC financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MEDIFAST main balance sheet or income statement drivers, such as Depreciation And Amortization of 13.8 M, Selling General Administrative of 753.6 M or Total Revenue of 1.1 B, as well as many exotic indicators such as Price To Sales Ratio of 0.65, Dividend Yield of 0.1 or PTB Ratio of 4.14. MEDIFAST financial statements analysis is a perfect complement when working with MEDIFAST INC Valuation or Volatility modules.
  
This module can also supplement MEDIFAST INC's financial leverage analysis and stock options assessment as well as various MEDIFAST INC Technical models . Check out the analysis of MEDIFAST INC Correlation against competitors.
For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.

MEDIFAST INC Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets325.4 M309.9 M191.4 M
Slightly volatile
Short and Long Term Debt Total23.1 M22 M11.4 M
Slightly volatile
Other Current Liabilities49 M46.6 M30.6 M
Slightly volatile
Total Current Liabilities96.9 M92.3 M62.9 M
Slightly volatile
Total Stockholder Equity211.6 M201.5 M118.9 M
Slightly volatile
Property Plant And Equipment Net70.5 M67.1 M41 M
Slightly volatile
Cash99.2 M94.4 M66.2 M
Slightly volatile
Non Current Assets Total90.2 M85.9 M46.7 M
Slightly volatile
Cash And Short Term Investments157.5 M150 M88.7 M
Slightly volatile
Net Receivables9.2 M8.7 M2.2 M
Slightly volatile
Common Stock Total Equity12.3 K12.7 K12.1 K
Very volatile
Common Stock Shares Outstanding12.2 M10.9 M11.8 M
Very volatile
Liabilities And Stockholders Equity325.4 M309.9 M191.4 M
Slightly volatile
Inventory27.8 M54.6 M43.4 M
Slightly volatile
Other Current Assets5.5 M10.7 MM
Slightly volatile
Total Liabilities113.8 M108.4 M72.5 M
Slightly volatile
Property Plant And Equipment Gross120.1 M114.4 M52.3 M
Slightly volatile
Total Current Assets235.2 M224 M144.7 M
Slightly volatile
Common Stock12.2 K12.7 K12.1 K
Very volatile
Accounts Payable21.4 M39.2 M31.8 M
Slightly volatile
Other Assets21.5 M20.5 M6.5 M
Slightly volatile
Property Plant Equipment69.1 M65.8 M36.2 M
Slightly volatile
Net Tangible Assets125 M178.3 M115.9 M
Slightly volatile
Retained Earnings Total Equity126.9 M160.8 M115.5 M
Slightly volatile
Other Liabilities177.8 K187.2 K1.3 M
Slightly volatile
Short and Long Term Debt277.2 K197.1 K306.4 K
Slightly volatile
Non Current Liabilities Other246.2 K259.2 K1.1 M
Slightly volatile
Cash And Equivalents100.8 M100.8 M77.2 M
Slightly volatile
Net Invested Capital163.2 M201.5 M130.8 M
Slightly volatile
Net Working Capital113.4 M131.7 M96.8 M
Slightly volatile
Capital Stock9.3 K9.9 K11.6 K
Slightly volatile
Deferred Long Term Asset Charges2.4 M2.7 M2.9 M
Slightly volatile

MEDIFAST INC Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization13.8 M13.1 M7.8 M
Slightly volatile
Selling General Administrative753.6 M717.8 M403.8 M
Slightly volatile
Total Revenue1.1 B1.1 B642.3 M
Slightly volatile
Gross Profit814.6 M775.9 M472.3 M
Slightly volatile
Other Operating Expenses992.9 M945.7 M564.7 M
Slightly volatile
Operating Income132.7 M126.4 M77.6 M
Slightly volatile
EBIT132.7 M126.4 M77.7 M
Slightly volatile
EBITDA146.5 M139.5 M85.5 M
Slightly volatile
Cost Of Revenue311 M296.2 M170 M
Slightly volatile
Total Operating Expenses681.9 M649.4 M394.7 M
Slightly volatile
Income Before Tax135.2 M128.8 M78.5 M
Slightly volatile
Net Income104.4 M99.4 M59 M
Slightly volatile
Net Income Applicable To Common Shares173.4 M165.1 M68 M
Slightly volatile
Net Income From Continuing Ops73.5 M119.9 M64.1 M
Slightly volatile
Tax Provision26.5 M31.5 M19.6 M
Slightly volatile
Interest Income2.6 M2.5 M912.7 K
Slightly volatile
Reconciled DepreciationM12.7 M5.9 M
Slightly volatile
Selling And Marketing Expenses2.6 M1.5 M4.3 M
Slightly volatile

MEDIFAST INC Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow92.1 M87.7 M60.5 M
Slightly volatile
Depreciation13.8 M13.1 M7.8 M
Slightly volatile
Capital Expenditures7.2 M6.5 M9.3 M
Pretty Stable
Net Income104.4 M99.4 M59.5 M
Slightly volatile
End Period Cash Flow99.2 M94.4 M66.2 M
Slightly volatile
Stock Based Compensation4.6 M8.2 M4.8 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.650.68241.4493
Pretty Stable
Dividend Yield0.10.09980.0348
Slightly volatile
PTB Ratio4.143.63126.8916
Slightly volatile
Days Sales Outstanding2.822.97133.6264
Slightly volatile
Book Value Per Share19.4418.511710.1186
Slightly volatile
Invested Capital0.140.10930.3307
Pretty Stable
Stock Based Compensation To Revenue0.00730.00760.0086
Pretty Stable
PB Ratio4.143.63126.8916
Slightly volatile
EV To Sales0.580.61491.3572
Pretty Stable
ROIC0.460.43660.3722
Slightly volatile
Inventory Turnover5.75.42594.0929
Pretty Stable
Net Income Per Share9.599.1345.0958
Slightly volatile
Days Of Inventory On Hand63.9167.270295.9989
Pretty Stable
Payables Turnover4.217.55764.542
Slightly volatile
Sales General And Administrative To Revenue0.660.690.6209
Slightly volatile
Research And Ddevelopement To Revenue0.00270.00430.0036
Slightly volatile
Cash Per Share14.4713.78557.5282
Slightly volatile
Days Payables Outstanding93.6448.2959100
Slightly volatile
ROE0.840.49340.4359
Slightly volatile
PE Ratio6.997.359319.7152
Slightly volatile
Return On Tangible Assets0.340.32080.2507
Slightly volatile
Earnings Yield0.140.13590.0658
Slightly volatile
Intangibles To Total Assets0.00360.00380.007
Slightly volatile
Current Ratio2.312.42722.6649
Slightly volatile
Tangible Book Value Per Share19.4418.511710.1026
Slightly volatile
Receivables Turnover163111323
Pretty Stable
Graham Number64.7661.680232.8877
Slightly volatile
Shareholders Equity Per Share19.4418.511710.1186
Slightly volatile
Debt To Equity0.140.10930.3307
Pretty Stable
Average Receivables4.1 M3.9 M1.1 M
Slightly volatile
Revenue Per Share10398.498255.1971
Slightly volatile
Interest Debt Per Share1.192.02242.426
Very volatile
Debt To Assets0.06750.0710.2244
Pretty Stable
Enterprise Value Over EBITDA4.494.725111.6947
Pretty Stable
Price Earnings Ratio6.997.359319.7152
Slightly volatile
Operating Cycle66.7370.241599.6254
Pretty Stable
Price Book Value Ratio4.143.63126.8916
Slightly volatile
Days Of Payables Outstanding93.6448.2959100
Slightly volatile
Pretax Profit Margin0.130.12010.1096
Slightly volatile
Ebt Per Ebit0.741.01890.9664
Pretty Stable
Operating Profit Margin0.120.11790.1082
Slightly volatile
Company Equity Multiplier1.061.53811.5612
Very volatile
Long Term Debt To Capitalization0.07040.07410.1134
Very volatile
Total Debt To Capitalization0.09360.09850.1421
Pretty Stable
Return On Capital Employed0.610.58090.5097
Slightly volatile
Debt Equity Ratio0.140.10930.3307
Pretty Stable
Ebit Per Revenue0.120.11790.1082
Slightly volatile
Quick Ratio1.241.72011.7584
Slightly volatile
Net Income Per E B T0.810.77190.7584
Very volatile
Cash Ratio0.671.02321.1387
Very volatile
Days Of Inventory Outstanding63.9167.270295.9989
Pretty Stable
Days Of Sales Outstanding2.822.97133.6264
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.920.95610.9264
Pretty Stable
Price To Book Ratio4.143.63126.8916
Slightly volatile
Fixed Asset Turnover16.7715.974114.6069
Slightly volatile
Enterprise Value Multiple4.494.725111.6947
Pretty Stable
Debt Ratio0.06750.0710.2244
Pretty Stable
Price Sales Ratio0.650.68241.4493
Pretty Stable
Return On Assets0.340.32080.2504
Slightly volatile
Asset Turnover1.83.45932.8643
Slightly volatile
Net Profit Margin0.09740.09270.0792
Slightly volatile
Gross Profit Margin0.540.72370.7097
Very volatile
Price Fair Value4.143.63126.8916
Slightly volatile
Return On Equity0.840.49340.4359
Slightly volatile

MEDIFAST INC Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap465.9 M443.7 M404.9 M
Slightly volatile
Enterprise Value417.1 M397.2 M364.9 M
Slightly volatile

MEDIFAST Fundamental Market Drivers

Cash And Short Term Investments150 M

MEDIFAST Upcoming Events

20th of February 2024
Upcoming Quarterly Report
View
6th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
20th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About MEDIFAST INC Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include MEDIFAST INC income statement, its balance sheet, and the statement of cash flows. MEDIFAST INC investors use historical funamental indicators, such as MEDIFAST INC's revenue or net income, to determine how well the company is positioned to perform in the future. Although MEDIFAST INC investors may use each financial statement separately, they are all related. The changes in MEDIFAST INC's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on MEDIFAST INC's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on MEDIFAST INC Financial Statements. Understanding these patterns can help to make the right decision on long term investment in MEDIFAST INC. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue574 K545.3 K
Total Revenue1.1 B1.1 B
Cost Of Revenue296.2 M311 M
Stock Based Compensation To Revenue 0.01  0.01 
Sales General And Administrative To Revenue 0.69  0.66 
Research And Ddevelopement To Revenue 0  0 
Capex To Revenue(0.01)(0.01)
Revenue Per Share 98.50  103.42 
Ebit Per Revenue 0.12  0.12 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether MEDIFAST INC is a strong investment it is important to analyze MEDIFAST INC's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact MEDIFAST INC's future performance. For an informed investment choice regarding MEDIFAST Stock, refer to the following important reports:
Check out the analysis of MEDIFAST INC Correlation against competitors.
For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.
Note that the MEDIFAST INC information on this page should be used as a complementary analysis to other MEDIFAST INC's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Complementary Tools for MEDIFAST Stock analysis

When running MEDIFAST INC's price analysis, check to measure MEDIFAST INC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MEDIFAST INC is operating at the current time. Most of MEDIFAST INC's value examination focuses on studying past and present price action to predict the probability of MEDIFAST INC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MEDIFAST INC's price. Additionally, you may evaluate how the addition of MEDIFAST INC to your portfolios can decrease your overall portfolio volatility.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Is MEDIFAST INC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MEDIFAST INC. If investors know MEDIFAST will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MEDIFAST INC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.77)
Dividend Share
4.95
Earnings Share
9.1
Revenue Per Share
98.498
Quarterly Revenue Growth
(0.43)
The market value of MEDIFAST INC is measured differently than its book value, which is the value of MEDIFAST that is recorded on the company's balance sheet. Investors also form their own opinion of MEDIFAST INC's value that differs from its market value or its book value, called intrinsic value, which is MEDIFAST INC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MEDIFAST INC's market value can be influenced by many factors that don't directly affect MEDIFAST INC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MEDIFAST INC's value and its price as these two are different measures arrived at by different means. Investors typically determine if MEDIFAST INC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MEDIFAST INC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.